(Q54245801)

English

IEVM chemotherapy with rhGM-CSF support for aggressive non-Hodgkin's lymphomas: a pilot study.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/8471659

IEVM chemotherapy with rhGM-CSF support for aggressive non-Hodgkin's lymphomas: a pilot study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/8471659

author name string

J Walther

1

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/8471659

W Wilmanns

2

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/8471659

H H Gerhartz

3

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/8471659

publication date

1 March 1993

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/8471659

Annals of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/8471659

66

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/8471659

3

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/8471659

135-137

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/8471659

Results of recent salvage chemotherapy regimens for lymphoma and Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/8471659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intervention treatment of established neutropenia with human recombinant granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in patients undergoing cancer chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8471659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8471659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of ifosfamide and its metabolites on intracellular glutathione levels in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/8471659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma Study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8471659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/8471659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01697623

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/8471659

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/8471659

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54245801&oldid=1388691452"